SLNO FY 2017 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SLNOSoleno Therapeutics, Inc.

$2B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$1.6B-107145.4% YoY

Gross Profit

-$1.6B100.1% margin

Operating Income

-$12M0.8% margin

Net Income

-$16M1.0% margin

EPS (Diluted)

$-26.18

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$880,031

Balance Sheet

Total Assets

$39M

Total Liabilities

$12M

Stockholders' Equity

$27M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$1.6B	$1M	-107145.4%
Gross Profit	-$1.6B	-$58,518	-2656540.7%
Operating Income	-$12M	-$14M	+10.6%
Net Income	-$16M	-$12M	-29.9%